Adiposogenital dystrophy medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Adiposogenital dystrophy}} | {{Adiposogenital dystrophy}} | ||
==Overview== | ==Overview== | ||
The genital signs, low [[Basal metabolic rate|B.M.R.]], and [[obesity]] in many cases disappear | The genital signs, low [[Basal metabolic rate|B.M.R.]], and [[obesity]] in many cases disappear during or after puberty without any treatment due to genital development and with the correction of [[Basal metabolic rate|B.M.R.]]. The genital under-development seen in adiposogenital dystrophy responds to injections of [[pregnancy]] [[urine]] extract follutein (Squibb). | ||
==Medical therapy== | ==Medical therapy== | ||
The genital under-development seen in adiposogenital dystrophy responds to injections of [[pregnancy]] [[urine]] extract follutein (Squibb)<ref name="pmidhttps://doi.org/10.1210/endo-23-5-637">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.1210/endo-23-5-637 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref> | The genital under-development seen in adiposogenital dystrophy responds to injections of [[pregnancy]] [[urine]] extract follutein (Squibb)<ref name="pmidhttps://doi.org/10.1210/endo-23-5-637">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.1210/endo-23-5-637 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref> | ||
Revision as of 02:14, 18 August 2021
|
Adiposogenital dystrophy Microchapters |
|
Differentiating Adiposogenital dystrophy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Adiposogenital dystrophy medical therapy On the Web |
|
American Roentgen Ray Society Images of Adiposogenital dystrophy medical therapy |
|
Risk calculators and risk factors for Adiposogenital dystrophy medical therapy |
Overview
The genital signs, low B.M.R., and obesity in many cases disappear during or after puberty without any treatment due to genital development and with the correction of B.M.R.. The genital under-development seen in adiposogenital dystrophy responds to injections of pregnancy urine extract follutein (Squibb).
Medical therapy
The genital under-development seen in adiposogenital dystrophy responds to injections of pregnancy urine extract follutein (Squibb)[1]
References
- ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.1210/endo-23-5-637 Check
|pmid=value (help).